Risk factors of suicidal ideation in Huntington’s disease: literature review and data from Enroll-HD

被引:0
|
作者
Philipp Honrath
Imis Dogan
Olga Wudarczyk
Katharina S. Görlich
Mikhail Votinov
Cornelius J. Werner
Beate Schumann
Rena T. Overbeck
Jörg B. Schulz
Bernhard G. Landwehrmeyer
Raquel E. Gur
Ute Habel
Kathrin Reetz
机构
[1] RWTH Aachen University Hospital,Department of Neurology
[2] RWTH Aachen University,Department of Neurology, Section Interdisciplinary Geriatrics
[3] RWTH Aachen University,Department of Psychiatry, Psychotherapy and Psychosomatics
[4] Institute of Molecular Neuroscience and Neuroimaging,JARA
[5] Institute of Brain Structure-Function Relationships,BRAIN, Jülich
[6] University of Ulm,Aachen Research Alliance
[7] University of Pennsylvania,JARA
来源
Journal of Neurology | 2018年 / 265卷
关键词
Huntington’s disease; Depression; Suicidal ideation; Risk factors; Enroll-HD;
D O I
暂无
中图分类号
学科分类号
摘要
Suicide is a leading cause of death in Huntington’s disease (HD), following pneumonia. Up to one-fifth of individuals with HD report suicidal ideation. Identifying the risk factors of suicidal ideation in this clinical population is thus pivotal. Here, we review the literature on prevalence rates and risk factors of suicidal ideation in premanifest and manifest patients and re-evaluate them using the largest currently existing clinical dataset from the ongoing observational study “Enroll-HD” (N = 5709). Large scale studies yielded important insights regarding suicidal ideation in HD. However, estimated prevalence rates vary among studies and risk factors are still poorly understood. According to the Enroll-HD data, pre- and manifest disease stages are associated with current (5.8–10%) and a history of suicidal ideation (18.6–30.9%). Throughout the course of HD, a history of suicidal ideation and the presence of depressive symptoms were strongly associated with current suicidal ideation. However, while for premanifest individuals, socio-demographics and activities of daily living appear to be important, in manifest patients, suicidal ideation is more closely linked to anxiety, irritability, psychosis, and apathy. These results highlight the importance of treating depressive symptoms in patients with HD and addressing potential suicidal ideation during clinical monitoring. The relevance of risk factors may differ among premanifest and manifest patients.
引用
收藏
页码:2548 / 2561
页数:13
相关论文
共 50 条
  • [1] Risk factors of suicidal ideation in Huntington's disease: literature review and data from Enroll-HD
    Honrath, Philipp
    Dogan, Imis
    Wudarczyk, Olga
    Goerlich, Katharina S.
    Votinov, Mikhail
    Werner, Cornelius J.
    Schumann, Beate
    Overbeck, Rena T.
    Schulz, Joerg B.
    Landwehrmeyer, Bernhard G.
    Gur, Raquel E.
    Habel, Ute
    Reetz, Kathrin
    JOURNAL OF NEUROLOGY, 2018, 265 (11) : 2548 - 2561
  • [2] Data from ENROLL-HD: Is the prevalence of juvenile and pediatric Huntington's disease overestimated?
    Achenbach, Jannis
    Saft, Carsten
    PARKINSONISM & RELATED DISORDERS, 2021, 88 : 1 - 2
  • [3] Sex Differences in Huntington's Disease: Evaluating the Enroll-HD Database
    Hentosh, Samantha
    Zhu, Liang
    Patino, Jorge
    Furr, J. Weldon
    Rocha, Natalia P.
    Furr Stimming, Erin
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2021, 8 (03): : 420 - 426
  • [4] Risk Factors for Suicidal Ideation in People at Risk for Huntington's Disease
    Anderson, Karen E.
    Eberly, Shirley
    Groves, Mark
    Kayson, Elise
    Marder, Karen
    Young, Anne B.
    Shoulson, Ira
    JOURNAL OF HUNTINGTONS DISEASE, 2016, 5 (04) : 389 - 394
  • [5] Prevalence of neurocognitive disorder in Huntington's disease using the Enroll-HD dataset
    Sierra, Luis A.
    Ullman, Clementina J.
    Baselga-Garriga, Clara
    Pandeya, Sarbesh R.
    Frank, Samuel A.
    Laganiere, Simon
    FRONTIERS IN NEUROLOGY, 2023, 14
  • [6] Longitudinal Treatment Patterns of Chorea in North American Patients with Huntington's Disease: Data from Enroll-HD
    Stimming, Erin Furr
    Claassen, Daniel O.
    Sen, Ginny P.
    Klepitskaya, Olga
    Serbin, Michael
    Kim, Hyunwoo
    Hinton, Sean C.
    Haubenberger, Dietrich
    NEUROLOGY AND THERAPY, 2025, : 743 - 756
  • [7] Memantine Use and Cognitive Decline in Huntington's Disease: An Enroll-HD Study
    Ogilvie, Amy C.
    Schultz, Jordan L.
    MOVEMENT DISORDERS CLINICAL PRACTICE, 2023, 10 (07): : 1120 - 1125
  • [8] Enroll-HD: An Integrated Clinical Research Platform and Worldwide Observational Study for Huntington's Disease
    Sathe, Swati
    Ware, Jen
    Levey, Jamie
    Neacy, Eileen
    Blumenstein, Robi
    Noble, Simon
    Muhlback, Alzbeta
    Rosser, Anne
    Landwehrmeyer, G. Bernhard
    Sampaio, Cristina
    FRONTIERS IN NEUROLOGY, 2021, 12
  • [9] The Clinical Picture of Psychosis in Manifest Huntington's Disease: A Comprehensive Analysis of the Enroll-HD Database
    Rocha, Natalia P.
    Mwangi, Benson
    Candano, Carlos A. Gutierrez
    Sampaio, Cristina
    Stimming, Erin Furr
    Teixeira, Antonio L.
    FRONTIERS IN NEUROLOGY, 2018, 9
  • [10] Machine learning in Huntington's disease: exploring the Enroll-HD dataset for prognosis and driving capability prediction
    Ouwerkerk, Jasper
    Feleus, Stephanie
    van der Zwaan, Kasper F.
    Li, Yunlei
    Roos, Marco
    van Roon-Mom, Willeke M. C.
    de Bot, Susanne T.
    Wolstencroft, Katherine J.
    Mina, Eleni
    ORPHANET JOURNAL OF RARE DISEASES, 2023, 18 (01)